Joong Bae Ahn

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi et al. · Annals of Oncology · 2017 · 592 citations · Full text

Medicine, Oncology, Surgery +16

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Yong Sang Hong, Byung‐Ho Nam, Kyu-pyo Kim et al. · The Lancet Oncology · 2014 · 384 citations

Medicine, Oncology, Surgery +17

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Jianming Xu, Tae Won Kim, Lin Shen et al. · Journal of Clinical Oncology · 2017 · 257 citations

Medicine, Oncology, Pharmacotherapy +9

VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers

Chang Gon Kim, Mi Jang, Youngun Kim et al. · Science Immunology · 2019 · 254 citations · Full text

Medicine, Immunology, Oncology +16

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

Seong Ha Cheon, Sun Young Rha, Hei‐Cheul Jeung et al. · Annals of Oncology · 2008 · 188 citations · Full text

Medicine, Oncology, Surgery +17